ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$9.26
-1.44%
Mkt Cap $2.23B
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
Implied Upside
+101.7%
Consensus $18.67 vs current $9.26
NASDAQ·Healthcare·Biotechnology
$9.26
-1.44%
Mkt Cap $2.23B
Buy
4
Hold
1
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
+101.7%
Consensus $18.67 vs current $9.26